#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12062	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2103	567.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	710	C	690	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22384	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3631	613.0	0	.	n	.	0	T695C	SNP	695	695	T	1103	1103	C	720	C,T,A	695,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22384	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3631	613.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2046	2046	G	707	G,A	690,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22384	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3631	613.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2379	2379	C	741	C,G	723,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22384	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3631	613.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2453	2453	A	713	A	705	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22384	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3631	613.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3005	3005	C	674	C	649	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1572	folP	852	852	99.77	folP.l15.c4.ctg.1	1531	102.1	0	.	p	.	0	S68P	NONSYN	202	204	TCG	513	515	CCG	168;166;163	C;C;G	160;159;153	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1572	folP	852	852	99.77	folP.l15.c4.ctg.1	1531	102.1	0	.	p	.	0	A204V	NONSYN	610	612	GCA	921	923	GTA	145;143;143	G;T,C;A	139;135,1;139	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	1572	folP	852	852	99.77	folP.l15.c4.ctg.1	1531	102.1	1	SNP	p	R228S	1	.	.	682	684	AGC	993	995	AGC	151;151;150	A;G;C	146;147;143	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4568	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3290	137.9	1	SNP	p	S91F	1	.	.	271	273	TTC	559	561	TTC	183;181;183	T;T;C	178;175;173	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4568	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3290	137.9	1	SNP	p	G95N	0	.	.	283	285	GGC	571	573	GGC	180;178;176	G;G;C	175;173;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4568	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3290	137.9	1	SNP	p	D95G	1	.	.	283	285	GGC	571	573	GGC	180;178;176	G;G;C	175;173;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1452	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1403	102.9	1	SNP	p	G45D	0	.	.	133	135	GGC	497	499	GGC	190;189;188	G;G;C	184;187;184	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	734	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1133	64.6	0	.	n	.	0	A197.	DEL	197	197	A	679	679	A	156	A	152	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4014	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2727	145.5	1	SNP	p	D86N	0	.	.	256	258	GAC	446	448	GAC	163;164;164	G;A;C	157;155;157	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4014	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2727	145.5	1	SNP	p	R87W	0	.	.	259	261	CGT	449	451	CGT	167;169;169	C;G;T	160;163;161	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4014	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2727	145.5	1	SNP	p	R87I	0	.	.	259	261	CGT	449	451	CGT	167;169;169	C;G;T	160;163;161	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4014	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2727	145.5	1	SNP	p	S87R	1	.	.	259	261	CGT	449	451	CGT	167;169;169	C;G;T	160;163;161	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4014	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2727	145.5	1	SNP	p	S88P	0	.	.	262	264	TCC	452	454	TCC	167;168;169	T;C;C,A	160;159;160,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3512	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2563	135.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1481	1483	GGC	199;197;197	G;G;C	190;186;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1289	1291	GCC	140;139;140	G;C;C	133;136;133	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1292	1294	ATG	143;141;143	A;T;G	141;138;139	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1304	1306	ACC	150;149;148	A;C;C,A	141;145;143,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1304	1306	ACC	150;149;148	A;C;C,A	141;145;143,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1805	1807	ACC	165;164;164	A;C;C	158;159;158	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1859	1861	GCG	150;149;149	G;C;G,T	145;143;143,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1859	1861	GCG	150;149;149	G;C;G,T	145;143;143,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1982	1984	GGT	130;130;130	G;G;T	123;121;123	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1991	1993	AGC	127;127;126	A,G;G;C,T	119,1;120;117,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3120	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2396	129.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2009	2011	CCG	102;104;102	C,G;C,G,A;G	94,4;93,2,1;86	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4612	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3173	144.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1661	1663	CCG	168;167;167	C;C;G	151;161;154	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1998	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1770	111.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	526	526	C	130	C,G	123,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2376	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1737	135.0	1	SNP	p	G120K	1	.	.	358	360	AAG	700	702	AAG	169;168;167	A,C;A;G,A	164,1;166;156,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2376	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1737	135.0	1	SNP	p	N121D	0	.	.	361	363	AAC	703	705	AAC	170;172;175	A;A;C,A	165;167;167,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2376	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1737	135.0	1	SNP	p	A121N	1	.	.	361	363	AAC	703	705	AAC	170;172;175	A;A;C,A	165;167;167,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7868	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4892	159.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	942	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1115	84.1	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	180;181;182	A;T;G	173;174;176	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
